Clinical Trial Update: Dacorin for Proliferative Vitreoretinopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Dacorin for proliferative vitreoretinopathy conducted at Cairo University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy

Drugs mentioned

• Dacorin

Snippet

Sponsor: Cairo University | Conditions: PVR | Phase 1, Phase 2 | Status: COMPLETED